Alhamdulillah, we are proud to announce the successful launch of NEO-MUNE®, the second product in our EN range, in Pakistan today, September 1, 2025. This marks another significant step forward in Otsuka’s commitment to advancing clinical nutrition and enhancing patient care.

NEO-MUNE® is specially formulated to address the complex nutritional needs of patients undergoing cancer treatment. In alignment with international nutritional guidelines, it is designed to support strength, recovery, treatment adherence, and overall quality of life.
 

Our field teams are actively engaging with healthcare professionals to introduce NEO-MUNE® across key medical institutions nationwide. The launch reflects our unified approach under the One Otsuka vision, bringing together the collaborative efforts of our IV, PN, and EN teams.

To maximize visibility and impact, we have also featured a prominent advertisement in Dawn Newspaper (Back Page) one of the country’s leading publications:

Please find the link below to view the published advertisement for your reference:
https://epaper.dawn.com/?page=01_09_2025_012